Ribosome Inactivating Proteins, Type 2
"Ribosome Inactivating Proteins, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ribosome inactivating proteins consisting of two polypeptide chains, the toxic A subunit and a lectin B subunit, linked by disulfide bridges. The lectin portion binds to cell surfaces and facilitates transport into the ENDOPLASMIC RETICULUM.
Descriptor ID |
D054790
|
MeSH Number(s) |
D08.811.277.450.430.700.750 D12.776.765.678.906 D12.776.765.710.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ribosome Inactivating Proteins, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Ribosome Inactivating Proteins, Type 2".
This graph shows the total number of publications written about "Ribosome Inactivating Proteins, Type 2" by people in this website by year, and whether "Ribosome Inactivating Proteins, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ribosome Inactivating Proteins, Type 2" by people in Profiles.
-
Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins. Arzneimittelforschung. 2000 May; 50(5):471-8.
-
Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs. 1997 Apr; 8 Suppl 1:S3-8.
-
Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett. 1996 Dec 03; 109(1-2):33-8.
-
Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins. Anticancer Drugs. 1992 Oct; 3(5):507-11.